Calendar Eli Lilly and Company

Equities

LLY

US5324571083

Real-time Estimate Cboe BZX 10:11:36 2024-02-29 am EST 5-day change 1st Jan Change
751 USD -0.87% Intraday chart for Eli Lilly and Company -2.84% +28.29%

Chart calendar Eli Lilly and Company

15a412df1135c2803f817cda0f40b.XHYV3LpIDJGSCEqZx_AG2mvBDG1rrNJFWtaTEQ5penA.Njx9ldIlVdf4ZiTcrsFxsTqDbVgYgZEzHbL7aGIFIjU0EUSGzSZj4uM7IQ~42cd8c60da6b547da5baca7e121befc4

Upcoming events on Eli Lilly and Company

2024-03-06 09:10 am TD Cowen Health Care Conference - Fireside Chat
2024-04-30 06:25 am Q1 2024 Earnings Release
2024-04-30 10:00 am Q1 2024 Earnings Call
2024-08-08 06:25 am Q2 2024 Earnings Release
2024-08-08 10:00 am Q2 2024 Earnings Call
2024-10-30 06:25 am Q3 2024 Earnings Release
2024-10-30 10:00 am Q3 2024 Earnings Call
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-11-03 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

2024-02-13 Ex-dividend day
2024-02-06 10:00 am Q4 2023 Earnings Call
2024-02-06 06:45 am Q4 2023 Earnings Release
2024-01-09 05:15 pm JPMorgan Healthcare Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No:5152
2023-12-11 08:00 pm American Society of Hematology Meeting - Abstract No:981
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3269
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3626
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3026
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No:1660
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No:1737
2023-12-09 07:15 pm American Society of Hematology Meeting - Abstract No:326
2023-12-09 American Society of Hematology Meeting - Abstract No:325
2023-12-08 10:35 am San Antonio Breast Cancer Symposium - Abstract #: 1569529
2023-12-07 07:12 am San Antonio Breast Cancer Symposium - Abstract #: 1545518
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Abstract #: 1549969
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Abstract #: 1577336
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Abstract #: 1575371
2023-12-06 08:00 am San Antonio Breast Cancer Symposium - Abstract #: 1580352
2023-12-05 12:45 pm San Antonio Breast Cancer Symposium - Abstract #: 1643629

Past dividends on Eli Lilly and Company

2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD
2021-11-11 Quarterly 0.85 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
22 320
22 142
0.8%
24 540
24 394
0.6%
28 318
28 205
0.4%
28 541
28 641
-0.35%
34 124
33 585
1.6%

41 318

EBITDA
Million USD
Released
Forecast
Spread
7 551
7 508
0.57%
8 589
8 676
-1.01%
10 005
9 767
2.43%
9 473
9 494
-0.23%
8 584
8 418
1.98%

14 731

EBIT
Million USD
Released
Forecast
Spread
6 079
6 106
-0.44%
7 265
7 503
-3.17%
8 457
8 599
-1.65%
7 950
8 164
-2.62%
7 057
6 928
1.86%

13 384

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 266
8 975
-41.33%
7 230
7 041
2.68%
6 156
7 148
-13.88%
6 806
7 084
-3.93%
6 555
6 311
3.86%

12 686

Net income
Million USD
Released
Forecast
Spread
8 318
8 090
2.83%
6 194
5 805
6.69%
5 582
6 019
-7.27%
6 245
6 102
2.35%
5 240
5 307
-1.26%

10 997

EPS
USD
Released
Forecast
Spread
8,89
8,65
2.83%
6,79
6,36
6.69%
6,12
6,43
-4.75%
6,90
6,60
4.57%
5,80
6,04
-3.92%

12,1

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
8 000
7 887
1.43%
7 810
7 319
6.7%
6 488
6 854
-5.33%
6 942
6 901
0.58%
7 302
7 376
-1%
6 960
6 867
1.36%
8 312
7 590
9.51%
9 499
8 965
5.96%
9 353
8 971
4.27%

8 964


9 875


10 711


11 737


10 745

EBITDA
Million USD
Released
Forecast
Spread
2 982
2 595
14.9%
3 046
2 717
12.12%
1 679
2 387
-29.67%
2 373
2 385
-0.5%
2 375
2 268
4.72%
1 982
2 148
-7.73%
2 618
2 416
8.39%
986
3 460
-71.49%
2 855
3 517
-18.81%

2 860


3 162


3 899


4 527




EBIT
Million USD
Released
Forecast
Spread
2 536
2 648
-4.23%
2 610
2 336
11.74%
1 330
1 790
-25.7%
2 010
2 007
0.13%
2 000
1 953
2.41%
1 620
1 840
-11.95%
2 252
2 078
8.37%
575
921
-37.56%
2 468
2 448
0.79%

2 717


3 011


3 570


4 109




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread


















2 089
2 107
-0.86%
427
-399
207.07%
2 509
1 248
101.03%

2 455


2 617


3 059


3 787




Net income
Million USD
Released
Forecast
Spread
1 726
1 760
-1.93%
1 903
1 711
11.22%
953
1 133
-15.93%
1 452
1 453
-0.09%
1 938
1 681
15.27%
1 345
1 544
-12.9%
1 763
1 660
6.22%
-57,4
-813
92.94%
2 190
1 811
20.89%

2 106


2 417


2 850


3 502




EPS
USD
Released
Forecast
Spread
1,90





1,05
1,85
-43.24%
1,61
1,90
-15.26%
2,14
1,78
20.22%
1,49
2,04
-26.96%
1,95
1,81
7.73%
-0,06
-0,66
90.91%
2,42
2,26
7%

2,45


2,57


3,11


3,78




Announcement Date03/02/2228/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW